Title
Dermatomyositis: An Acute Flare and Current Treatments.
Funding Source
National Institute on Minority Health and Health Disparities
Grant Number
D34HP00006-28-0
Department
College of Pharmacy
Document Type
Article
Publication Date
6-1-2019
Abstract
The purpose of this case report is to assess and review the literature to determine the frequency of occurrence of dermatomyositis (DM). Dermatomyositis is a rare autoimmune condition that disproportionately affects adolescence and pediatric patients. The symptomatology experienced in this condition includes but not limited to fatigue, reduced mobility, and dysphagia. Symptoms of dysphonia and dyspnea have been reported due to weakened esophageal and respiratory muscle. Another major complication seen in DM is calcinosis. Calcinosis is a calcium deposit on soft tissue. This is mostly been attributed to late diagnosis or use of ineffective treatment regimen. Systemic corticosteroid is the first-line treatment for DM; however, other agents such as anti-malaria, IVIG, and immunosuppressive therapies have been used successfully.
Recommended Citation
Okogbaa, John I. Dr. and Batiste, L., "Dermatomyositis: An Acute Flare and Current Treatments." (2019). Faculty and Staff Publications. 243.
https://digitalcommons.xula.edu/fac_pub/243
Comments
DOI: 10.1177/1179547619855370
Funding text
FunDIng: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was support partially by the Grant, 5 S21 MD 000100-12, from the National Institute on Minority Health and Health Disparities (NIMHD), and D34HP00006-28-0 from Health Resource and Service Administration of DHHS. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the NIH, NIMHD, HRSA or DHHS.